Pharmaceutical statisticians have come a long way over the past half century, evolving from backroom number-crunchers to essential contributors across the entire drug development spectrum. Haoda Fu and Amy Xia discuss where the field may be headed.
Amstat News
The Membership Magazine of the American Statistical Association